Clinical study on postoperative treatment of ankle joint fracture with Jie-Gu-Qi-Li tablets
Phase 4
Recruiting
- Conditions
- Ankle fracture
- Registration Number
- ITMCTR2000003162
- Lead Sponsor
- Shanghai Sixth People's Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
The diagnosis of ankle fracture was confirmed by imaging examination; it was in accordance with the operation indications; the patient signed the informed consent.
Exclusion Criteria
Patients with neurological and vascular injuries; patients with severe osteoporosis and other diseases affecting ankle function; patients with cognitive dysfunction and mental disorders; patients with poor compliance.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Jie-Gu-Qi-Li tablet efficacy in ankle fracture repair?
How does Jie-Gu-Qi-Li compare to standard-of-care treatments for postoperative ankle fractures in clinical outcomes?
Are there specific biomarkers associated with response to Jie-Gu-Qi-Li in ankle fracture patients?
What are the potential adverse events and safety management strategies for Jie-Gu-Qi-Li postoperative use in ankle fractures?
What related compounds or combination therapies are being explored for ankle fracture treatment alongside Jie-Gu-Qi-Li?